Myomo EPS - Earnings per Share 2016-2024 | MYO
Myomo eps - earnings per share from 2016 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Myomo Annual EPS | |
|---|---|
| 2024 | $-0.16 |
| 2023 | $-0.28 |
| 2022 | $-1.52 |
| 2021 | $-1.89 |
| 2020 | $-3.67 |
| 2019 | $-20.79 |
| 2018 | $-25.18 |
| 2017 | $-87.99 |
| 2016 | $-124.02 |
| 2015 | $-134.84 |
| Myomo Quarterly EPS | |
|---|---|
| 2024-12-31 | $0.00 |
| 2024-09-30 | $-0.03 |
| 2024-06-30 | $-0.03 |
| 2024-03-31 | $-0.10 |
| 2023-12-31 | $-0.07 |
| 2023-09-30 | $-0.06 |
| 2023-06-30 | $-0.04 |
| 2023-03-31 | $-0.11 |
| 2022-12-31 | $-0.29 |
| 2022-09-30 | $-0.40 |
| 2022-06-30 | $-0.42 |
| 2022-03-31 | $-0.41 |
| 2021-12-31 | $-0.50 |
| 2021-09-30 | $-0.36 |
| 2021-06-30 | $-0.46 |
| 2021-03-31 | $-0.57 |
| 2020-12-31 | $0.66 |
| 2020-09-30 | $-0.70 |
| 2020-06-30 | $-1.12 |
| 2020-03-31 | $-2.51 |
| 2019-12-31 | $-4.60 |
| 2019-09-30 | $-4.87 |
| 2019-06-30 | $-4.50 |
| 2019-03-31 | $-6.82 |
| 2018-12-31 | $-6.56 |
| 2018-09-30 | $-6.31 |
| 2018-06-30 | $-6.31 |
| 2018-03-31 | $-6.01 |
| 2017-12-31 | $65.47 |
| 2017-09-30 | $-6.31 |
| 2017-06-30 | $-100.60 |
| 2017-03-31 | $-46.55 |
| 2016-12-31 | $0.00 |
| 2016-09-30 | $-32.73 |
| 2016-06-30 | $-28.23 |
| 2015-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.171B | $0.033B |
| Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts. | |||